Scarica l'app Stockscreener
77.55
2.39%
-1.90
Pre-mercato:
77.73
0.18
+0.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$79.45
Aprire:
$79.28
Volume 24 ore:
15.77M
Relative Volume:
1.40
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.49%
1M Prestazione:
+4.33%
6M Prestazione:
-22.46%
1 anno Prestazione:
-13.72%
Intervallo 1D:
$77.20
$79.44
Intervallo di 1 settimana:
$75.68
$80.07
Portata 52W:
$66.66
$105.47
Spdr Biotech Etf Stock (XBI) Company Profile
Nome
Spdr Biotech Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta XBI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XBI
Spdr Biotech Etf
|
77.55 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
289.22 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
586.84 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
589.94 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
232.94 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
515.59 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf Borsa (XBI) Ultime notizie
Zacks Investment Ideas feature highlights: Alibaba, JD.com, SPDR S&P Biotech ETF, Merck and Microsoft - Yahoo Finance
XBI: Some Tariff Relief Right Now, But Macro Risks Remain In Biotech (NYSEARCA:XBI) - Seeking Alpha
MBB Leads With $1.2B Gain as Markets React to UK Trade Deal - TradingView
XBI, EXAS, ALNY, NTRA: Large Outflows Detected at ETF - Nasdaq
(XBI) Investment Analysis - news.stocktradersdaily.com
XBI, Biotech Stocks Retreat: Buy, Hold or Sell? - ETF.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
SPDR S&P Biotech ETF Target of Unusually High Options Trading (NYSEARCA:XBI) - Defense World
Optimism is Back for Biotech Stocks. This Time, It Could Last. - MSN
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Optimism Is Back for Biotech Stocks. This Time, It Could Last. - Barron's
Renaissance Technologies LLC Purchases Shares of 5,500 SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Should You Invest in the VanEck Biotech ETF (BBH)? - Nasdaq
ETFs That Outperform the S&P 500: ARKK, VGT, IWF, XBI - Markets.com
(XBI) On The My Stocks Page - news.stocktradersdaily.com
Alliancebernstein L.P. Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 Best Health Care Funds and ETFs for 2025 | Investing | U.S. News - Money/ US News
O Shaughnessy Asset Management LLC Has $65,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Biotech stocks to own amid market volatility – Piper Sandler (XBI:NYSEARCA) - Seeking Alpha
Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets - Yahoo Finance
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
How the (XBI) price action is used to our Advantage - news.stocktradersdaily.com
Should You Invest in the iShares Biotechnology ETF (IBB)? - Nasdaq
11 Stocks to Buy After the Biotech Bloodbath - Barron's
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies - Asianet Newsable
Wednesday's ETF Movers: XBI, PICK - Nasdaq
XBI Crosses Critical Technical Indicator - Nasdaq
Analysts at Cantor, formerly headed by Lutnick, call for Kennedy's dismissal - Reuters
Biotech stocks plunge as FDA’s Peter Marks resigns over RFK Jr. dispute, Moderna and Beam Therapeutics hit hard - TradingView
Bank of New York Mellon Corp Reduces Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Long Term Trading Analysis for (XBI) - news.stocktradersdaily.com
Trump administration cancels $12 billion in funding to state health departments (XBI:NYSEARCA) - Seeking Alpha
Proficio Capital Partners LLC Buys 5,225 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
Sequoia Financial Advisors LLC Trims Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
How Is Biogen's Stock Performance Compared to Other Biotech Stocks? - TradingView
(XBI) Investment Report - Stock Traders Daily
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank - Armenian Reporter
Assetmark Inc. Sells 588,528 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Healthcare Sector Trying To Bounce Back - Seeking Alpha
Atria Investments Inc Buys 1,043 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
2Seventy Bio (TSVT): Surge Following Acquisition Announcement - Value The Markets
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by US Bancorp DE - Defense World
Form 424B2 MORGAN STANLEY - StreetInsider.com
Steward Partners Investment Advisory LLC Sells 814 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
(XBI) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Guarantor: JPMorgan Chase & Co. - StreetInsider.com
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value the Markets
Spdr Biotech Etf Azioni (XBI) Dati Finanziari
Non sono disponibili dati finanziari per Spdr Biotech Etf (XBI). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):